Bevacizumab Biosimilar - Research Grade

Human

VEGF

1.0 - 5.0 mg/ml

Human IgG1

Humanized

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human VEGF. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Bevacizumab.

Blue ice

Vascular endothelial growth factor (VEGF) is a central driver of angiogenesis and a long-standing target in oncology and vascular biology research. This research-grade anti-human VEGF recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of bevacizumab, engineered around the VEGF target for research use only. Manufactured to in vivo standards as an ultra-pure, low-endotoxin human IgG1, it is supplied in scalable milligram to gram quantities to meet the demands of high-throughput and bulk laboratories. It is widely applicable as a control and active reagent across preclinical studies, including VEGF neutralisation assays, in vitro angiogenesis screening, and in vivo tumour models.

Vascular endothelial growth factor

P15692

ICH3001-100ml ICH3002-100ml ICH3003-100ml

https://www.imgt.org/mAb-DB/